DexCom, Inc. logo

DexCom, Inc. (DXCM)

Market Closed
16 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
87. 34
+0.89
+1.0295%
$
31.33B Market Cap
134.71 P/E Ratio
- Div Yield
3.54M Volume
1.43 Eps
$ 86.45
Previous Close
Add Transaction
Day Range
86.05 88.79
Year Range
54.11 92.59
Want to track DXCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DexCom (DXCM) Accused of Misleading Investors - Hagens Berman

DexCom (DXCM) Accused of Misleading Investors - Hagens Berman

SAN FRANCISCO, CA / ACCESSWIRE / August 22, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Accesswire | 2 years ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Contact Levi & Korsinsky by October 21, 2024 Deadline to Join Class Action Against DexCom, Inc. (DXCM)

Contact Levi & Korsinsky by October 21, 2024 Deadline to Join Class Action Against DexCom, Inc. (DXCM)

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
The Schall Law Firm Encourages Shareholders In DexCom Inc To Join The Investigation Into Possible Securities Law Violations

The Schall Law Firm Encourages Shareholders In DexCom Inc To Join The Investigation Into Possible Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 2 years ago
Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Levi & Korsinsky Notifies Shareholders of DexCom, Inc.(DXCM) of a Class Action Lawsuit and an Upcoming Deadline

Levi & Korsinsky Notifies Shareholders of DexCom, Inc.(DXCM) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Will DexCom Stock Rebound To Its 2021 Highs Of $160?

Will DexCom Stock Rebound To Its 2021 Highs Of $160?

DexCom stock (NASDAQ: DXCM) currently trades at $73 per share, around 55% below the highs of $163 seen in November 2021. In comparison, Insulet stock (NASDAQ: PODD) saw its stock decline 39% over the same period.

Forbes | 2 years ago
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM

Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Loading...
Load More